Search Page
Filters
Search Results
158 results
Results are displayed in a computed author sort order.
The Publication Date timeline is not available.
Page 1
Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
Cancer Res. 1995 Feb 1;55(3):505-9.
Cancer Res. 1995.
PMID: 7834618
Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Cancer Res. 1995 Dec 15;55(24):6200-9.
Cancer Res. 1995.
PMID: 8521414
p16INK4A as a human tumor suppressor.
Biochim Biophys Acta. 1996 Mar 18;1242(3):165-9. doi: 10.1016/0304-419x(95)00011-4.
Biochim Biophys Acta. 1996.
PMID: 8603068
Review.
No abstract available.
p16INK4A participates in a G1 arrest checkpoint in response to DNA damage.
Mol Cell Biol. 1998 Jan;18(1):378-87. doi: 10.1128/MCB.18.1.378.
Mol Cell Biol. 1998.
PMID: 9418885
Free PMC article.
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility.
Oncogene. 1999 Jan 7;18(1):67-77. doi: 10.1038/sj.onc.1202273.
Oncogene. 1999.
PMID: 9926921
Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines.
Clin Cancer Res. 1999 Oct;5(10):2925-38.
Clin Cancer Res. 1999.
PMID: 10537362
The physiology of p16(INK4A)-mediated G1 proliferative arrest.
Cell Biochem Biophys. 2000;33(2):189-97. doi: 10.1385/CBB:33:2:189.
Cell Biochem Biophys. 2000.
PMID: 11325039
Review.
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.
Clin Cancer Res. 2001 Jun;7(6):1590-9.
Clin Cancer Res. 2001.
PMID: 11410495
Clinical Trial.
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
J Clin Endocrinol Metab. 1997 Sep;82(9):3025-8. doi: 10.1210/jcem.82.9.4197.
J Clin Endocrinol Metab. 1997.
PMID: 9284737
Cite